Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer

PURPOSE: Brain metastases of breast cancer appear to be increasing in incidence, confer significant morbidity, and threaten to compromise gains made in systemic chemotherapy. The blood-tumor barrier (BTB) is compromised in many brain metastases, however, the extent to which this influences chemother...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Lockman, Paul R., Mittapalli, Rajendar K., Taskar, Kunal S., Rudraraju, Vinay, Gril, Brunilde, Bohn, Kaci A., Adkins, Chris E., Roberts, Amanda, Thorsheim, Helen R., Gaasch, Julie A., Huang, Suyun, Palmieri, Diane, Steeg, Patricia S., Smith, Quentin R.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2010
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2999649/
https://ncbi.nlm.nih.gov/pubmed/20829328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1564
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים